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Abstract 
DNA is compacted into the cell nucleus through the formation of chromatin, which consists 
of DNA wound around octamers of histone proteins into nucleosomes. Chromatin that is 
accessible, or “open” is associated with active gene transcription, while inaccessible, or “closed” 
chromatin with intact nucleosomes is thought to be transcriptionally repressed. To identify 
sequence signatures in open chromatin, we use a technique called Formaldehyde Assisted 
Isolation of Regulatory Elements (FAIRE). Currently, FAIRE can only be performed on fresh 
tissues or cells. We wanted to extend our protocol to include formalin-fixed paraffin embedded 
(FFPE) human biopsy samples since these samples are readily available in tissue banks. 
However, the only available protocol for extracting chromatin from FFPE samples requires an 
enzyme that degrades open chromatin, making it incompatible with FAIRE. As an alternative to 
chemical extraction, we used nanodroplets, in combination with acoustic sonication, to 
mechanically disrupt FFPE tissue samples. This novel method sufficiently disrupted FFPE 
samples and fragmented chromatin to make it compatible with FAIRE analysis. Since fixation 
times in pathology labs range from a few hours to several days, we will next test whether FFPE 
tissue fixation times affect our ability to extract chromatin. We hypothesize that the addition of 
nanodroplets to the FAIRE protocol would normalize the quantity and quality of isolated 
chromatin independent of tissue fixation time. If successful, our protocol could be applied as a 
screening assay or diagnostic for diseases with aberrantly open or closed chromatin signatures. 
Introduction 
The mechanisms of tumor formation are not only limited to gene mutations, but also 
include epigenetic modifications. The latter refers to heritable changes in gene expression, such 
as DNA methylation and histone acetylation that are independent of any modifications to the 
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DNA sequence1. Such changes can alter the packaging of DNA, which in turn could affect the 
ability of transcription factors to access DNA1. Hence, epigenetic modifications can induce 
aberrant activation or repression of genes, thereby promoting tumor formation and growth. Since 
chromatin is a complex of DNA and histones that packages DNA to fit into a cell nucleus, any 
changes in the chromatin structure can affect gene expression. One example of cancer linked to a 
specific change in chromatin signature is Ewing sarcoma, a rare type of pediatric cancer in bones 
and soft tissues2. This disease is characterized by a chromosomal translocation involving the 
EWSR1 and FLI1 genes, resulting in an oncoprotein called EWS-FLI1 that causes aberrant 
opening of chromatin at specific regions of DNA2. Dr. Ian Davis’s lab used a technique called 
Formaldehyde Assisted Isolation of Regulatory Elements (FAIRE) to isolate open chromatin and 
demonstrate that loss of EWS-FLI1 protein through mRNA knockdown results in closing of 
aberrantly open chromatin and suppression of tumor cell growth2. Therefore, these disease-
specific regions of open chromatin have the potential to be used as a diagnostic for Ewing 
sarcoma, further emphasizing the importance of chromatin signature in tumor formation. Hence, 
devising a standard method to extract high quality chromatin from all types of tissues that is 
compatible with all downstream chromatin-based assays is very desirable and likely to advance 
the field of oncological medicine. 
We used FAIRE to isolate active regulatory elements from eukaryotic chromatin and 
analyze chromatin signature3. Active regulatory elements refer to sequences of DNA that are 
responsible for regulating DNA-templated processes such as transcription3. DNA is organized 
differently in different regions of our chromosomes. These regions are categorized as either 
euchromatin or heterochromatin based on nucleosome density. Euchromatic regions, also known 
as open chromatin, with low nucleosome density tend to be more accessible to transcription 
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machinery compared to regions of heterochromatin associated with tightly packed nucleosomes4. 
The nucleosome is the fundamental unit of chromatin composed of DNA wrapped around a set 
of eight proteins called histones5. It plays an important role in gene regulation since its presence 
reduces the ability of enzymes, such as RNA polymerase II, to access DNA for transcription. 
Therefore, nucleosome depletion is generally a marker for active gene expression6. 
By isolating open chromatin, the FAIRE technique allows for the identification of 
regulatory elements in eukaryotes, such as promoters. The original procedure of FAIRE involves 
three steps: crosslinking DNA to proteins using 
formaldehyde, shearing the chromatin by sonication, and 
performing a phenol/chloroform extraction3 (Fig 1). Since 
open chromatin containing active regulatory elements is 
depleted of nucleosomes, the crosslinking phase only 
involves nucleosome-rich, or closed regions of chromatin. 
As a result, shearing by sonication essentially divides the 
chromatin into two regions: open and closed. The 
phenol/chloroform solution is then used to separate the 
two regions by forming two phases: organic and aqueous. 
Due to its rich nature of proteins, closed chromatin 
segregates into the organic phase, while the open 
chromatin of interest, containing mostly negatively charged DNA, gets segregated to the aqueous 
phase. Although this technique can work with a broad range of cell types, we have modified the 
third phase of the procedure by replacing the phenol/chloroform extraction with silica-containing 
columns7. These columns are simple to use and do not require toxic chemicals like chloroform. 
 
 
Fig. 1: The FAIRE technique makes it 
possible to isolate “open” or 
transcriptionally active regions of 
chromatin that are associated with 
gene regulation3.    
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By pouring the sonicated solution containing a mixture of open and closed chromatin through the 
column, the negatively charged DNA from the open chromatin binds to the positively charged 
silica, while the DNA from closed chromatin passes right through the column due to the presence 
of proteins that weaken the negatively charged DNA. In other words, columns work by taking 
advantage of the differential isoelectric point between DNA bound by proteins and free DNA. 
Hence, our modified FAIRE offers a simple method for identifying regions of open chromatin. 
Our experiments involve tissue or cultured cell pellets that have been Formalin-Fixed 
(FF) and Paraffin Embedded (PE). Due to its inexpensive nature and long-term storage potential, 
FFPE samples offer the best choice for preserving and processing specimens in pathology 
departments8. However, the use of FFPE samples limits us on the ways chromatin can be 
extracted. Currently, the only available method for the extraction of chromatin from FFPE 
samples requires an enzyme called micrococcal nuclease that degrades open chromatin, which in 
turn makes it incompatible with the FAIRE method9. Hence, a method that extracts chromatin 
without degrading it is very desirable. 
We investigated if mechanical disruption of FFPE samples using nanodroplets could 
replace enzymatic digestion for the extraction of chromatin from FFPE samples. Nanodroplets 
are a cavitation enhancement agent developed in Paul Dayton’s lab that contains perfluorocarbon 
(PFC). In particular, nanodroplets are nano-sized particles containing liquefied PFC surrounded 
by a phospholipid monolayer10. They can easily be made from microbubbles, which are particles 
widely used in ultrasound imaging, by mechanical agitation followed by compression and 
cooling11. Nanodroplets vaporize into microbubbles when subjected to sufficient acoustic energy 
and temperature. Upon moderate acoustic pressures (2.4 MHz), the microbubble shell will 
undergo a rapid cycle of expansion and contraction called cavitation, where the velocity of the 
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bubble wall can move up to 700 meters per second10. At higher acoustic pressures, which can be 
achieved by the E110 Covaris Sonicator, microbubble cavitation becomes intense to the point 
that it violently collapses, releasing tremendous mechanical energy responsible for the extraction 
and fragmentation of chromatin10. We use nanodroplets instead of microbubbles because 
nanodroplets require energy to not only vaporize but also to cavitate, thereby extending the 
cavitation enhancement effect compared to microbubbles alone10. By incorporating nanodroplets 
during sonication of FFPE samples, we showed that nanodroplets provide sufficient energy 
needed to extract chromatin from such samples, thereby obviating the use of micrococcal 
nuclease in chromatin extraction. 
Before devising a standardized protocol that involves the use of chromatin from FFPE 
samples, there are certain factors that we need to consider, such as tissue type and duration of 
fixation. Fixation times in pathology labs tend to range from a few hours to couple of days, such 
as samples being left fixed over the weekend. We are interested in testing whether FFPE tissue 
fixation times affect our ability to extract chromatin using nanodroplets. We hypothesize that the 
addition of nanodroplets to the FAIRE protocol would normalize the quantity and quality of 
isolated chromatin independent of tissue fixation time. Here, I describe and test the optimization 
of the protocol for nanodroplet-mediated extraction of chromatin from FFPE samples including 
rodent xenograft tissue that has been fixed for various time points. 
Method 
1. FFPE FAIRE protocol 
1.1 Deparaffinizing - 
Our protocol was tested on FFPE EWS894 Ewing sarcoma cell pellets and rodent xenograft 
tissue (with a known chromatin signature), as well as FFPE MCF-7 luminal breast carcinoma 
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rodent xenograft tissue that was fixed for 4, 24, and 48 hours. A slide containing the FFPE 
sample was obtained and placed in a slide holder. The holder was then placed in a tub containing 
150 mL xylene for 3 minutes. This was repeated three times in different tubs of xylene, before 
draining and blotting the excess solution from the holder.  
1.2 Hydration - 
The holder containing the FFPE sample was placed in a tub containing 150 mL 100% ethanol 
for 3 minutes, before moving it to another tub of 100% ethanol for the same period of time. The 
above procedure was repeated but in a tub of 85% ethanol instead (15% de-ionized water). The 
holder was then placed in a new tub of 150 mL 70% ethanol (30% de-ionized water) for 3 
minutes, before moving the holder to a tub containing 150 mL de-ionized water for 3 minutes. 
The slides were then blotted by pressing it between paper towels. Using a razor blade, the sample 
was scrapped off the slide and deposited into a 8MM clear round bottom crimp vials (Thermo 
Scientific #C4008-632R) 
1.3 Sonication - 
FAIRE buffer (10mM Tris-HCl pH 8.0, 2% Triton-X-100, 1% SDS, 100mM NaCl, 1mM 
EDTA) was added to the vial containing the sample followed by 10 µL of nanodroplets (courtesy 
of Paul Dayton). The vial was then capped (Thermo Scientific #C4008-2A) and sonicated in a 
Covaris E110 Sonicator at 4°C for 4 minutes with the following settings: 20% duty cycle; 
intensity = 8; and 200 cycles per burst. The sonication cycle was then repeated for an additional 
4 minutes for a total of 8 minutes sonication. There was a 5 minute limit for continuous 
sonication of a single tube, due to possible degradation of DNA. The lysate was transferred to a 
1.5 mL Eppendorf tube and centrifuged at 4°C for 5 minutes. The supernatant containing the 
DNA of interest was then separated from the pellet by pipetting.  
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1.41 DNA Recovery –  
This method was used to determine the cell lysis efficiency and calculate DNA recovery. 
After separating the supernatant from the pellet from the sonication step, the pellet was 
resuspended in 100 µL FAIRE buffer. Two µL proteinase K was then added to both the pellet 
and the supernatant tubes. The tubes were mixed and briefly centrifuged, followed by incubation 
at 55⁰C overnight. On the following day, 2µL RNase was added to both the pellet and 
supernatant tubes and incubated at 37⁰C for 10 minutes. Using the Zymo kit, the DNA was 
extracted and purified from both the pellet and supernatant tubes, followed by elution of DNA 
using a 25µL elution buffer. To calculate DNA recovery, the Qubit 2.0 flurometer was used to 
determine the amount of DNA in the pellet and the supernatant. The amount of DNA in the 
supernatant was divided by the amount of DNA left over in the pellet. Fragmentation efficiency 
was verified by running the DNA on a 1.5% agarose gel. 
1.42 FAIRE - 
This method was used to determine open chromatin recovery. After separating the 
supernatant from the pellet from the sonication step, the supernatant with the DNA of interest 
was digested with 2 µL of RNase at 37⁰C for 10 minutes. Before performing FAIRE, 10% of the 
supernatant was transferred to a new 1.5 mL Eppendorf tubes to serve as input. Ninety µL 
FAIRE buffer was added to the input to bring the total volume to 100 µL. Two µL proteinase K 
was added to the input to get rid of the proteins surrounding the DNA. The tube was then 
inverted to mix and briefly centrifuged, followed by incubation at 55⁰C overnight. To perform 
FAIRE on the remaining 90% of the supernatant, the manufacturer’s instructions of the Zymo 
Kit (#D5201) was followed. The DNA was eluted to a final volume of 25 µL and placed in the 
fridge. On the following day, 2 µL RNase was added to the FAIRE DNA, followed by incubation 
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at 37⁰C for 10 minutes. The purified DNA was extracted from both the FAIRE DNA and the 
input solution using the Zymo kit and eluted to a final volume of 25 µL. The total amount of 
open chromatin was determined using a Qubit 2.0 fluorometer by dividing the quantity of FAIRE 
DNA by the input DNA. 
1.5 Quantitative PCR (qPCR) - 
 To assay individual loci associated with aberrantly open chromatin signatures, qPCR was 
utilized. We used four primer sets: a positive control (AURKAIP1), a negative control 
(BC006361), and two primers associated with Ewing sarcoma (P1 and P2) (See Appendix A). 
For each primer set, there were wells designated for Input DNA, FAIRE DNA, and a no template 
control. The master mix was prepared according to the number of wells used +2 (See Appendix 
B). For example, if two wells would be used, then a master mix for four wells would be 
prepared. Two µL of the appropriate DNA (Input or FAIRE) obtained from the FAIRE step of 
the protocol was added to its designated well. Eight µL master mix was then aliquoted per well 
containing the 2 µL of the appropriate DNA. The qPCR plate was sealed and briefly centrifuged 
before running the qPCR. The overview of the FFPE FAIRE protocol can be seen in Fig. 2.  
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2. Fixation time protocol 
This protocol was used to determine the effect of different fixation times on the quantity and 
purity of isolated chromatin from MCF-7 cell-derived xenograft tissue. This method involves 
three phases: 1) To quantify the amount of DNA present in MCF-7 cell-derived xenograft tissue 
2) To find the optimal sonication time for high ratios of supernatant to pellet and 3) To analyze 
the disease-specific regions of open chromatin using FAIRE and qPCR.  
2.1 Quantify total DNA per scroll 
The MCF-7 cell-derived xenograft tissues were deparafinzed and hydrated as outlined in the 
FFPE FAIRE protocol. The DNA was purified using the Biostic FFPE Tissue DNA Isolation Kit 
according to manufacturer’s instructions. After treatment with 2µL RNase and subsequent 
purification using the Zymo Kit, the total DNA was quantified using the Qubit 2.0 flurometer by 
following the Qubit Manual.  
2.2 Calculate DNA recovery 
After deparaffinization, hydration and sonication of MCF-7 scrolls, the DNA recovery part of 
the FFPE FAIRE protocol was followed.  
2.3 Perform FAIRE and qPCR 
This part of the protocol is identical to the FFPE FAIRE protocol for FAIRE and qPCR.  
Results 
Nanodroplets improve recovery and fragmentation of chromatin from FFPE samples 
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 The initial stages for the development of the protocol tested the possibility of chromatin 
A
. 
8 12
0
5
10
15
20
- Nanodroplets
+ Nanodroplets
Time (minutes)
D
N
A
 R
e
c
o
v
e
ry
 R
a
ti
o
(S
u
p
e
rn
a
n
ta
n
t/
P
e
ll
e
t) ND 
ND 
B 
Po
si
tiv
e
N
eg
at
iv
e
ES
1
ES
2
0.0
0.5
1.0
1.5
2.0
- Nanodroplets
+ Nanodroplets
qPCR Amplicon
P
e
rc
e
n
t 
In
p
u
t
ND 
ND 
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DNA obtained from the pellet. Error bars represent the standard deviation of three biological replicates. ND 
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extraction using nanodroplets in Ewing sarcoma FFPE cell pellets (EWS894 cells). Previous 
work by Anna Kenan and I showed that the addition of nanodroplets during acoustic sonication 
provided sufficient mechanical energy to disrupt regular cell pellets and fragment chromatin. We 
started with cell pellets instead of xenograft tissues because cell pellets are easily available, 
while xenograft tissues are expensive to generate. Further, Ian Davis’s lab has FAIRE next-
generation sequencing (FAIRE-seq) data for EWS894 cell lines, which makes FFPE cell pellets a 
logical place to start for the purposes of comparing data. To test the efficiency of chromatin 
extraction in FFPE cell pellets, we calculated DNA recovery in the presence and absence of 
nanodroplets. Our experiments reveal that the addition of nanodroplets significantly enhances 
DNA recovery compared to FFPE cell pellets without nanodroplets (Fig. 3A). This increase of 
DNA yield is also observed when FFPE cell pellets were sonicated for additional 4 minutes (Fig. 
3A). We then tested if our nanodroplet-disrupted samples could be used for the FAIRE assay. 
Analysis using quantitative PCR revealed that samples disrupted by nanodroplets produced 
increased FAIRE signals over background 
in chromatin regions that are always open 
as well as regions associated with Ewing 
sarcoma (Fig 3B). This result means that 
the use of nanodroplets increases 
chromatin recovery, which allowed us to 
detect good FAIRE signal over 
background. Moreover, as seen in Fig. 5, 
nanodroplets consistently produce around 
500 base pair fragment size in the 
Fig. 5: Gel electrophoresis of EWS894 cell pellets 
sonicated for 4 and 8 minutes.. +/- ND indicates 
presence or absence of nanodroplets respectively. The 
supernatant contains the DNA of interest while the 
pellet mostly contains debris. 
Pellet Supernatant 
8 8 4 4 
– – – – + + + + 
1500 
500 
ND 
  
12 
 
supernatant containing the DNA of interest compared to ones without nanodroplets. Further 
work by Anna Kenan revealed that nanodroplets also improve chromatin recovery and 
fragmentation from EWS894 FFPE xenograft tissues (Fig. 4A and 4B), thereby broadening the 
utility of our protocol. However, qPCR only involves specific regions of DNA, which limits us 
on the comparisons we can make with FAIRE-sequencing data from fresh Ewing sarcoma cell 
lines. We have therefore sent the FFPE xenograft tissue for next-generation sequencing in order 
to look at genome-wide DNA sequence. Nevertheless, our qPCR results helped us create a 
reliable protocol that has the potential to be used as a screening assay for diseases that have 
aberrantly open and closed chromatin signatures (Fig. 2).  
The effectiveness of nanodroplets is inversely proportional to formaldehyde fixation time 
 Due to a lack of time, we were unable to determine the effect of different fixation times on 
the quality of isolated chromatin using FAIRE by qPCR. Instead, we assessed the effect of 
different fixation times on chromatin recovery upon the addition of nanodroplets. This method 
involved obtaining three MCF-7 cell-derived xenograft tissues that were each fixed in 
formaldehyde at different times: 4 hours, 24 hours, and 48 hours. MCF-7 cells are a luminal 
breast carcinoma tissue culture cell line derived from a human tumor. Our lab surgically grafted 
MCF-7 cell to rodents that lack an effective immune system in order for tumors to form. In 
contrast to the two-dimensional aspect of cell pellets, xenograft tissues allow for three-
dimensional analysis of cells typical of tumors. Hence, MCF-7 cell-derived xenograft tissues 
provide a good tumor model for chromatin signature analysis. The first two phases of the fixation 
time protocol was then followed. Using the Biostic Kit followed by RNase treatment (Method 
2.1), we quantified the total amount of DNA present in these tissues (Table 1). Although total 
DNA varied between differently fixated scroll of MCF-7 tissues, this experiment gave us an idea 
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of the amount of DNA present overall (200-400ng) for comparisons with DNA obtained through 
nanodroplets. We then moved to the second phase of the protocol: to find the optimal sonication 
time for high ratios of supernatant containing the DNA of interest over pellet. We started with 12 
minutes sonication with and without nanodroplets but we found that a significant amount of 
DNA remained in the pellet even after the use of nanodroplets. This lack of soluble DNA is 
partly due to the complexity of tissues, which require more energy by nanodroplets to extract 
chromatin as when compared to cell pellets. As a result, we performed a similar experiment with 
16 minutes sonication (Fig. 6). The results reveal that, with the addition of nanodroplets, the 
highest increases in DNA recovery is seen in tissues fixed for 4 hours. The effectiveness of 
nanodroplets decreases when tissues are fixed for greater period of times, as seen in tissues fixed 
for 24 hours. This decrease continues until there is no signficiant difference between samples 
with nanodroplets and those without, as seen in tissues fixed for 48 hours. Therefore, not only 
does lengthy formaldehyde fixation impose a barrier on the extraction of DNA from FFPE 
samples, the results also reveal that the effectiveness of nanodroplets is inversely proportional to 
the duration of formalin-fixation. .  
Fixation 
Time 
DNA Extracted 
(ng/uL) 
Total DNA 
Obtained (ng) 
4 hours 3.54 ng/uL 177 ng 
24 hours 7.84 ng/uL 392 ng 
48 hours 4.82 ng/uL 241 ng 
Table 1: Total DNA obtained 
from a single scroll of MCF-7 
tissues that were fixed for 
varying hours. The DNA was 
extracted using the Biostic 
FFPE Tissue DNA Isolation Kit 
and treated with RNase. 
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Discussion 
The high DNA yield obtained from EWS894 FFPE cell pellets as well as xenograft 
tissues with the addition of nanodroplets compared to the ones without implies that nanodroplet 
cavitation has the ability to not only disrupt FFPE samples but also to extract and fragment 
chromatin (Fig. 3A and 4A). Since Ewing sarcoma is associated with aberrant opening of 
chromatin at specific DNA sequences2, we expect that nanodroplet cavitation will increase 
chromatin recovery on regions associated with the disease (ES1 and ES2). Indeed, the increase in 
DNA yield is concomitant with an increase in open chromatin associated with those regions (Fig. 
3B and 4B). The increase in FAIRE signal over background was also observed for chromatin 
regions that are always open (positive control), thereby confirming the effectiveness of 
nanodroplets. There was no significant increase in chromatin regions that are always closed 
(negative control), which confirms that FAIRE only isolates open chromatin. In addition, 
nanodroplet cavitation produced consistent DNA fragment size distribution (Fig. 5), which is 
important for next-generation sequencing, since the primers used in sequencing have a limit to 
the size of fragments they can extend. 
Fig. 6: Comparison of DNA 
recovery with and without 
nanodroplets at variously formalin-
fixed MCF-7 Xenograft tissue 
samples. Y-axis represents the ratio 
of the amount of DNA obtained 
from the supernatant compared to 
DNA obtained from the pellet. 
Error bars represent the standard 
deviation of three biological 
replicates. 
p=0.04 
p=0.07 p=0.24 
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 An alternative method available for the extraction of chromatin from FFPE samples 
requires the use of micrococcal nuclease, an enzyme with both endo- and exo-nuclease activity, 
to digest unprotected DNA9. However, the use of micrococcal nuclease increases the 
susceptibility to open chromatin degradation, which in turn makes it an incompatible method for 
analyzing open chromatin signatures through FAIRE. By improving the recovery and 
fragmentation of chromatin, mechanical disruption of FFPE samples using nanodroplets can 
replace the micrococcal nuclease digestion step for the isolation of chromatin from FFPE 
samples. Therefore, for the first time, our protocol provides a tool for identifying regions of open 
chromatin from FFPE samples.  
We are in the process of determining if FAIRE-seq data from EWS894 xenograft samples 
compares well to that obtained from fresh EWS894 cells and frozen patient samples. This 
comparison is especially important if the protocol is to be used as a screening assay for diseases 
that have aberrantly open or closed chromatin signatures. There is a possibility that the use of 
nanodroplets could strip proteins off the chromatin and generate artificial open sequences, 
thereby creating discrepancy between the two sequencing data. Other factors could include 
degradation of samples caused by the aging of FFPE samples, thereby causing the chromatin to 
be less intact12. In addition, recovery of chromatin from FFPE tissue might not be sufficient to 
produce a strong signal over background with FAIRE compared to fresh or frozen tissues. 
Therefore, next-generation sequencing will be an integral part of our studies to analyze some of 
these variables by providing the genome-wide DNA sequence for the samples.  
Although FFPE represents the gold standard for storing pathology samples8, the amount of 
time a sample is fixed in formaldehyde vary in tissue banks. This means that the quantity and 
quality of chromatin extraction might vary depending on the time a tissue is fixed in 
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formaldehyde. Therefore, before devising a standardized protocol that involves the use of 
chromatin from FFPE samples, we need to determine a sonication time range for recovery of 
high quality chromatin from any type of tissue. Our results show that a significant amount of 
DNA remained in the pellet in the absence of nanodroplets in all variously fixed MCF-7 tissues 
(Fig. 6). DNA recovery from all these tissues fell below 1, which indicates that there is more 
DNA in the pellet compared to the supernatant. After the addition of nanodroplets, the total DNA 
yield in the supernatant increased for samples fixed for 4 hours, where a less significant effect 
was seen for samples fixed for 24 hours (Fig. 6). There was no improvement in DNA yield for 
samples fixed for 48 hours (Fig. 6). This finding indicates that a longer fixation period for FFPE 
samples imposes a barrier for DNA extraction even in the presence of nanodroplets. Further 
work, such as FAIRE and qPCR, will be performed on these samples to confirm if a similar 
effect is observed on open chromatin recovery.  
Before performing FAIRE and qPCR to assess the effect of fixation on chromatin recovery in 
the presence of nanodroplets, we intend to test on ways that can enhance the effect of 
nanodroplets on our current experiment. Since 16 minutes of sonication produced better results 
than 12 minutes for MCF-7 samples, our next step is to sonicate the differently fixated MCF-7 
cell-derived xenograft tissues for 20 minutes, taking into account the integrity of the chromatin. 
We hypothesize that 20 minutes sonication could improve DNA recovery, particularly for those 
samples fixed for longer periods of time (24 and 48 hours). If successful, we could generate a 
time window for optimal chromatin extraction in our standardized protocol based on the duration 
of fixation for certain FFPE samples. Lastly, next-generation seqeuncing would be performed to 
compare the FAIRE-sequencing data of MCF-7 cell-derived xenograft tissues with sequencing 
data from fresh cell lines or frozen tissue.  
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Appendix A: Quantitative PCR Primers 
Name Oligo Sequence 
AURKAIP1 Forward TATACCCGCAGGTCCAGAATCGTT 
AURKAIP1 Reverse AATAGCTCTAGACGCTTCCGCCTT 
 
BC006361 Forward TTCTCCAACTTTGGAAGCCCAGGA 
BC006361 Reverse TGTCTCCTTCTAGGCCCTCACAAT 
P1 Forward AAGGAAGGAAGGGAGGGACACATAC 
P1 Reverse CCTGTGAGTGTGACAGATTACTTGG 
P7 Forward GGGTGACAGAGTAAGATCCTGTCAGA 
P7 Reverse TGGGCGTGGTTCTCATGT 
 
Appendix B: qPCR Master Mix 
 PCR Master Mix (for each primer set)  
o 2.8µl de-ionized water per well 
o 0.1µl of Primer 1 [50µM] per well 
o 0.1µl Primer 2 [50µM] per well 
o 5µl of FastStart 2XSYBR Green Master Mix (Roche) per well 
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